Several companies are starting to work on a vaccine for the new H1N1 flu but the new vaccine would not be ready for Swine Flu Shot widespread use until October, as U.S. health officials said they are ready to move to large-scale production as soon as requested by national authorities and the WHO. The companies which has licensed to sell flu shot In the US are AstraZeneca’s MedImmune, Sanofi-Aventis SA, Novartis AG, and GlaxoSmithKline Plc (source: reuters.com).

Below is an article issued by the European Vaccine Manufacturer (EVM) that stated EVM members are working hard to complete the preparations needed to manufacture Swine Flu Shot (H1N1 vaccines) as quickly as possible, to help protect against this new pandemic threat.

U.S. scientists hope to have a key ingredient for a swine flu vaccine ready in early May, but tell The Associated Press that the novel virus grows slowly in eggs – the chief way flu vaccines are made. According to Sherry Terpenny, DO - the vaccine information center, the ingredient of regular flu shot are: Egg proteins, Gelatin, Polysorbate 80, Formaldehyde, Triton X100, Sucrose, Resin, Gentamycin and Thimerosal.

Within the article you will find frequently asked questions regarding The Flu Shot such as have manufacturers developed H1N1 vaccines, When will H1N1 vaccines become available, How safe and effective will the new H1N1 vaccines be, How many doses of H1N1 vaccine can be produced,  Will vaccines be provided to developing countries, Will manufacturers complete the production of vaccines for the upcoming influenza season, Which strain are manufacturers using for H1N1 vaccine production and more.

Complete read of Swine Flu Shot Production, Ingredients and The Frequently Asked Questions can be found here, in the pdf filetype (source: evm-vaccines.org).